Alba Grayston Morales: How IL-1 Signaling Drives Injury and Repair in The Ischaemic Brain
Alba Grayston Morales, Postdoctoral Researcher at CIML, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Glia, adding:
”Thrilled to share our latest work from my postdoc at the Brain Inflammation Group, University of Manchester, now out in Glia!
We show that microglial IL-1β is a key amplifier of early post-stroke injury, with the most pronounced benefits of its deletion seen in female mice.
Beyond acute inflammation, microglial IL-1β also shapes post-stroke neurogenesis in a region-specific way.
Together, these findings add a new piece to the puzzle of how IL-1 signaling drives injury and repair in the ischaemic brain, supporting a model in which microglial IL-1α and IL-1β play distinct, non-redundant roles after stroke.”
Title: Specific Deletion of Interleukin-1 Beta in Microglia Improves Acute Outcome and Modulates Neurogenesis After Ischemic Stroke
Authors: Alba Grayston, Margarida Baptista, Kelly Wemyss, Ruby Taylor, Grace Cullen, Syeda S. Jafree, Nadim Luka, Joshua R. Cox, Joanne E. Konkel, David Brough, Stuart M. Allan, Emmanuel Pinteaux
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 21, 2026, 08:43Joy Duemke: Optimizing Stem Cell Collection for Gene Therapy Success
-
Jul 21, 2026, 07:55A New Era of Precision Imaging for Venous Thromboembolism – JTH
-
Jul 21, 2026, 07:43How to Monitor and Manage Unfractionated Heparin in Practice – JTH
-
Jul 21, 2026, 07:23Arthur Allen: Advancing Outpatient Antithrombotic Stewardship Through ADAPT
-
Jul 21, 2026, 03:19Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026